Yu Ziqi, Song Mei, Chouchane Lotfi, Ma Xiaojing
Department of Microbiology and Immunology, Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065, USA.
Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Qatar Foundation, Doha P.O. Box 24144, Qatar.
Cancers (Basel). 2021 Jun 30;13(13):3276. doi: 10.3390/cancers13133276.
Breast cancer (BC) is one of the most diagnosed cancers worldwide and is the second cause of cancer related death in women. The most frequent cause of BC-related deaths, like many cancers, is metastasis. However, metastasis is a complicated and poorly understood process for which there is a shortage of accurate prognostic indicators and effective treatments. With the rapid and ever-evolving development and application of genomic sequencing technologies, many novel molecules were identified that play previously unappreciated and important roles in the various stages of metastasis. In this review, we summarize current advancements in the functional genomic analysis of BC metastasis and discuss about the potential prognostic and therapeutic implications from the recent genomic findings.
乳腺癌(BC)是全球诊断率最高的癌症之一,也是女性癌症相关死亡的第二大原因。与许多癌症一样,BC相关死亡最常见的原因是转移。然而,转移是一个复杂且了解甚少的过程,目前缺乏准确的预后指标和有效的治疗方法。随着基因组测序技术的快速发展和不断应用,许多新分子被鉴定出来,它们在转移的各个阶段发挥着以前未被认识到的重要作用。在这篇综述中,我们总结了BC转移功能基因组分析的当前进展,并讨论了近期基因组研究结果的潜在预后和治疗意义。